DNA compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

DNAGinkgo Bioworks Holdings, Inc.

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

DNAGinkgo Bioworks Holdings, Inc.

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DNA

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.3%▼−9.28%×0.54

May 8 '26±16.8%▼−13.47%×0.80

Q1 FY26±21.2%▼−30.48%×1.44

Q3 FY25±18.3%▼−20.80%×1.14

ADPT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.2%▲+7.18%×0.47

Q1 FY26±16.2%▲+4.72%×0.29

= impliedDNA realized, solidADPT realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Feb 6 '26

±13.4%

▼−4.25%

×0.32

Jan 12 '26±13.5%▲+15.86%×1.18

DNAGinkgo Bioworks Holdings, Inc.

11.25▼−11.68%· post 11.12

Mkt cap$754.9MRevenue$20MQ2 FY26Revenue$150MFY25

ADPTAdaptive Biotechnologies Corp

26.62▼−5.51%· post 26.60

ClosedOct 30 '26

Mkt cap$4.3BRevenue$72MQ2 FY26Revenue$277MFY25

Compare

ClosedOct 30 '26

DNAGinkgo Bioworks Holdings, Inc.

ADPTAdaptive Biotechnologies Corp

11.25▼−11.68%post 11.12

Price

26.62▼−5.51%post 26.60

$754.9M

Mkt cap

$4.3B

Q2 FY26$20M

Revenue

$72MQ2 FY26

FY25$150M

Revenue

$277MFY25

DNA11.25▼−11.68%vsADPT26.62▼−5.51%ClosedOct 30 '26